Skip to main content

Advertisement

Log in

Tissue-engineered fascia from vaginal fibroblasts for patientsneeding reconstructive pelvic surgery

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Mesh-augmented reconstructive surgery for pelvic organ prolapse (POP) does not meet clinical expectations. A tissue-engineered fascia equivalent needs to be developed.

Methods

Human vaginal fibroblasts (HVFs) from 10 patients were characterized in vitro. Eligible HVFs and a biodegradable scaffold were used to fabricate a fascia equivalent, which was then transplanted in vivo.

Results

The cultured HVFs were divided into high (n = 6) or low (n = 4) collagen I/III ratio groups. Cells of the high-ratio group exhibited significantly higher proliferation potential than those of the low-ratio group (P < 0.05). A fascia equivalent was made with HVFs of the high-ratio group. In the subsequent animal study, a well-organized neo-fascia formation containing HVFs could be traced up to 12 weeks after transplantation.

Conclusions

Our results suggest that a tissue-engineered fascia could be developed from HVFs in vitro and in vivo, which might be an effective treatment for POP in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

POP:

Pelvic organ prolapse

SUI:

Stress urinary incontinence

HVFs:

Human vaginal fibroblasts

PBS:

Phosphate-buffered saline

DMEM:

Dulbecco’s modified Eagle medium

FBS:

Fetal bovine serum

FITC:

Fluorescein isothiocyanate

DAPI:

4,6-Diamidino-2-phenylindole dihydrochloride

HRP:

Horseradish peroxidase

ECL:

Enhanced chemiluminescence

PLGA:

Poly-dl-lactico-glycolic acid

References

  1. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506

    Article  CAS  PubMed  Google Scholar 

  2. Bump RC, Norton PA (1998) Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 25:723–746

    Article  CAS  PubMed  Google Scholar 

  3. Silva WA, Karram MM (2005) Scientific basis for use of grafts during vaginal reconstructive procedures. Curr Opin Obstet Gynecol 17:519–529

    Article  PubMed  Google Scholar 

  4. Jia X, Glazener C, Mowatt G, MacLennan G, Bain C, Fraser C, Burr J (2008) Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. Br J Obstet Gynaecol 115:1350–1361

    CAS  Google Scholar 

  5. Baessler K, Maher CF (2006) Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol 18:560–566

    Article  PubMed  Google Scholar 

  6. Dwyer PL (2009) Minimally invasive surgery in urogynecology. Int Urogynecol J Pelvic Floor Dysfunct 20:485–486

    Article  Google Scholar 

  7. De Filippo RE, Yoo JJ, Atala A (2003) Engineering of vaginal tissue in vivo. Tissue Eng 9:301–306

    Article  PubMed  Google Scholar 

  8. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367:1241–1246

    Article  PubMed  Google Scholar 

  9. Mitterberger M, Marksteiner R, Margreiter E, Pinggera GM, Colleselli D, Frauscher F, Ulmer H, Fussenegger M, Bartsch G, Strasser H (2007) Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. Br J Urol Int 100:1081–1085

    Google Scholar 

  10. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, Erickson J, Huard J, Chancellor MB (2008) 1-Year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:881–883

    Article  CAS  PubMed  Google Scholar 

  11. Nakanishi Y, Chen G, Komuro H, Ushida T, Kaneko S, Tateishi T, Kaneko M (2003) Tissue-engineered urinary bladder wall using PLGA mesh-collagen hybrid scaffolds: a comparison study of collagen sponge and gel as a scaffold. J Pediatr Surg 38:1781–1784

    Article  PubMed  Google Scholar 

  12. Weiss RA, Weiss MA, Beasley KL, Munavalli G (2007) Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 33:263–268

    Article  CAS  PubMed  Google Scholar 

  13. Mäkinen J, Kähäri VM, Söderström KO, Vuorio E, Hirvonen T (1987) Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse. Eur J Obstet Gynecol Reprod Biol 24:319–325

    Article  PubMed  Google Scholar 

  14. Rosch R, Klinge U, Si Z, Junge K, Klosterhalfen B, Schumpelick V (2002) A role for the collagen I/III and MMP-1/-13 genes in primary inguinal hernia? BMC Med Genet 3:2

    Article  PubMed  Google Scholar 

  15. Zheng H, Si Z, Kasperk R, Bhardwaj RS, Schumpelick V, Klinge U, Klosterhalfen B (2002) Recurrent inguinal hernia: disease of the collagen matrix? World J Surg 26:401–408

    Article  PubMed  Google Scholar 

  16. Segev Y, Auslender R, Feiner B, Lissak A, Lavie O, Abramov Y (2009) Are women with pelvic organ prolapse at a higher risk of developing hernias? Int Urogynecol J Pelvic Floor Dysfunct 20:1451–1453

    Article  PubMed  Google Scholar 

  17. Chen G, Sato T, Ohgushi H, Ushida T, Tateishi T, Tanaka J (2005) Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh. Biomaterials 26:2559–2566

    Article  CAS  PubMed  Google Scholar 

  18. Vandevord PJ, Broadrick KM, Krishnamurthy B, Singla AK (2009) A comparative study evaluating the in vivo incorporation of biological sling materials. Urology (in press)

  19. Zong W, Zyczynski HM, Meyn LA, Gordy SC, Moalli PA (2007) Regulation of MMP-1 by sex steroid hormones in fibroblasts derived from the female pelvic floor. Am J Obstet Gynecol 196(349):e1–11

    PubMed  Google Scholar 

  20. Zong W, Meyn LA, Moalli PA (2009) The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod 80:367–374

    Article  CAS  PubMed  Google Scholar 

  21. Bhatia NN, Ho MH (2004) Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach. Curr Opin Obstet Gynecol 16:397–398

    Article  PubMed  Google Scholar 

  22. Lee CH, Moioli EK, Mao JJ (2006) Fibroblastic differentiation of human mesenchymal stem cells using connective tissue growth factor. Conf Proc IEEE Eng Med Biol Soc 1:775–778

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank MY Lee and YF Lin for their technical assistance. This study was supported by Taichung Veterans General Hospital and Tunghai University (TCVGH-T) grant no. 947808, 957802, and 967803.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vivian Cheng Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hung, MJ., Wen, MC., Hung, CN. et al. Tissue-engineered fascia from vaginal fibroblasts for patientsneeding reconstructive pelvic surgery. Int Urogynecol J 21, 1085–1093 (2010). https://doi.org/10.1007/s00192-010-1168-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-010-1168-3

Keywords

Navigation